×

Treatment of hyperinsulinemic hypoglycemia with exendin (9-39)

  • US 10,639,354 B2
  • Filed: 05/23/2016
  • Issued: 05/05/2020
  • Est. Priority Date: 05/22/2015
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating hyperinsulinemic hypoglycemia in a patient, the method comprising subcutaneously administering to the patient in need thereof a composition comprising a therapeutically effective amount of exendin(9-39) twice-per-day (BID), wherein the therapeutically effective amount is in the range of 10-30 mg exendin(9-39), wherein the composition is administered in a single injection with an injectate volume of 0.5 ml to 1 ml.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×